Earnings

Royalty Pharma published press releases by date and/or category

Royalty Pharma Declares Fourth-Quarter 2021 Dividend

NEW YORK, NY, October 15, 2021 – The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the fourth quarter of 2021 of $0.17 per Class A ordinary share. The dividend will be paid on December 15, 2021, to shareholders of record at the close of business

Royalty Pharma Declares Third-Quarter 2021 Dividend

NEW YORK, NY, July 16, 2021 – The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the third quarter of 2021 of $0.17 per class A ordinary share. The dividend will be paid on September 15, 2021, to shareholders of record at the close of business on

Royalty Pharma Declares Second-Quarter 2021 Dividend

NEW YORK, NY, April 15, 2021 - The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the second quarter of 2021 of $0.17 per class A share. The dividend will be paid on June 15, 2021, to shareholders of record at the close of business on May 20, 2021.

Royalty Pharma Reports Q4 2020 and Full-Year Results

NEW YORK , Feb. 17, 2021 - Double-digit growth in Net cash provided by operating activities (GAAP) and Adjusted Cash Flow $2.4 billion of acquisitions announced in 2020; maintained leading share of biopharma royalty funding market Increasing outlook for 2020-2025 Adjusted Cash Receipts CAGR to 7%-10%

Stay up to date

Subscribe to Royalty Pharma news and alerts

Subscribe